David W. Gryska, Director at PDL BIOPHARMA, INC. (PDLI), sold 40,000 shares at $2.74 ($110K) on 2020-12-30, disclosed to the SEC on 2020-12-31.
Open-market sale of $110k PDLI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.74 | 20,000 | $55K | 50.0% |
| 2 | $2.74 | 20,000 | $55K | 50.0% |
| Total | $2.74 avg | 40,000 | $110K | 100% |
| Filing → |
| SGEN | SELL | 2022-11-15 | $968K | — | Filing → |
| SGEN | SELL | 2022-04-21 | $1.2M | — | Filing → |
| SGEN | SELL | 2022-02-09 | $1.1M | — | Filing → |